Royal Canin Just Drew a Line Around Therapeutic Fresh. Here's What That Means for Your Shelf.

Mars made its fresh therapeutic line vet-exclusive from day one. That's a channel strategy signal with real implications for your assortment.

Royal Canin Just Drew a Line Around Therapeutic Fresh. Here's What That Means for Your Shelf.

A customer walks in asking if you carry fresh therapeutic food. You stock fresh. You stock therapeutic kibble. But fresh therapeutic? That's now a vet-only conversation, and Royal Canin just made sure of it.

Here's what just happened

Royal Canin launched Royal Canin Fresh Veterinary Diets in the U.S. the brand's first fresh food line and the first major therapeutic fresh offering from a legacy pet food giant. The line includes formulas for gastrointestinal issues, kidney support, and weight management. The catch: it's available only through veterinarians. No specialty retail. No online. No independent store shelf, even if you carry the rest of Royal Canin's therapeutic lineup. Mars drew the distribution line on day one.

Why this is actually a big deal

Fresh has been the fastest-growing segment in pet food for three years running, and therapeutic fresh has been the white-space question hanging over the category. Wellness fresh and raw have found their footing in specialty retail. Convenience fresh (the refrigerated kibble alternatives) sits in the impulse zone near checkout. But therapeutic fresh, the stuff a vet would prescribe for a dog with pancreatitis or a cat with kidney disease, has lived in limbo. Too perishable for most vet clinics to stock deeply. Too regulatory-heavy for most specialty retailers to want to touch.

Royal Canin just answered the question by claiming the entire therapeutic fresh tier for the vet channel and signaling that Mars believes the margin, the liability, and the customer trust all justify keeping it behind the prescription counter. This isn't a test market. This is Mars, owner of Royal Canin, Nutro, Greenies, and Iams, making a structural bet that fresh therapeutic belongs in the same distribution lane as prescription kibble.

For anyone running an independent store or stocking a fresh case, this is the moment the category formally split. Wellness fresh is yours to fight over. Therapeutic fresh just became someone else's lane.

What this means for the shelf

For the store owner: You can't compete on therapeutic fresh, and Royal Canin just saved you from trying. The liability, the cold chain complexity, and the prescriptive relationship all tilt toward the vet clinic. The good news: this also means vet clinics won't undercut your wellness fresh margin, at least not yet. Royal Canin's move keeps therapeutic fresh expensive and vet-exclusive, which protects the price ceiling on the fresh you do stock. Your play is to own the wellness and raw fresh conversation before a customer ever thinks to ask their vet about food.

For the buyer: This is your cue to draw a bright line in your fresh assortment strategy. Double down on wellness fresh, raw, and the convenience formats (single-serve, freeze-dried, air-dried) that vets won't bother stocking. Royal Canin just told you where the moat is. Don't waste margin dollars or cold case space chasing therapeutic claims you can't fulfill or defend. Stock the fresh a pet owner buys because they want to, not because a vet told them to.

For the DTC fresh brand: If your pitch includes therapeutic claims, digestive health angles, or prescription-adjacent language, Mars just showed you the distribution ceiling and the regulatory scrutiny coming with it. Vet-exclusive means Royal Canin doesn't have to fight you for specialty shelf space, but it also means they're betting the customer who needs therapeutic fresh will trust the vet's recommendation over your DTC story. If you're going after therapeutic fresh, you're now competing with a billion-dollar brand that has the vet relationship, the cold chain, and the regulatory cover you probably don't.

How we're thinking about it

This is a smart, defensive play by Mars, and it tells you more about where fresh is heading than any trade show keynote will. Royal Canin didn't launch fresh therapeutic into specialty retail because they don't need to. The vet channel gives them pricing power, liability cover, and a built-in prescriptive moat. Specialty retail gets the high-turn, high-touch wellness fresh business, which is lucrative but also means you're competing on story, format, and margin instead of medical necessity.

The risk for independent retailers isn't that Royal Canin will undercut you. It's that vet clinics become the fresh authority in the customer's mind, and wellness fresh starts to look like the cheaper, non-medical option instead of the premium choice. If a customer's vet is talking about fresh food, even if it's therapeutic, that changes the trust calculus when they walk into your store and see a different fresh brand in the case.

The opportunity is to own the fresh conversation before the vet visit happens. Royal Canin's therapeutic line won't touch your shelf, but it will touch your customer's perception of what fresh food is for. Get ahead of that.

Royal Canin just told specialty retail exactly where the fresh category splits: wellness is yours, therapeutic is theirs, and the customer's vet is now in the fresh business.

If this is the kind of operator-level read you want every week, subscribe to PetRetailNews.

What to do about it

  1. If you stock fresh but haven't trained your floor staff on the wellness vs. therapeutic distinction... script the response now. When a customer asks if you carry therapeutic fresh, the answer is: "That's a vet-channel product, but here's the wellness fresh we stock that supports [digestive health / weight management / whatever the customer mentioned], and here's why it's different." Don't cede the fresh authority to the vet by default.

  2. If you're a category buyer deciding which fresh brands to bring in... prioritize the ones with strong wellness positioning, clean format stories (raw, freeze-dried, single-serve), and no therapeutic claims that put you in regulatory gray area. Royal Canin just made the therapeutic lane harder to justify on your shelf.

  3. If you're a DTC fresh brand with a vet-channel strategy... watch how Royal Canin prices this line and what the sell-through looks like in six months. If therapeutic fresh moves at vet clinics, you'll need a different story to get independent retail buyers to take a bet on your version. If it doesn't, the whole category might stay wellness-focused longer than anyone thought.

  4. If you run a store near a vet clinic that's aggressive about retail... this is your early warning. If that clinic starts stocking Royal Canin Fresh, they're signaling they want a piece of the fresh business, not just the prescription business. Your counter-move is to make your fresh case the better experience: more variety, better sampling, staff who can talk about ingredients without sounding clinical.

The Bottom Line

Royal Canin just validated fresh as a category worth a billion-dollar brand's investment, then locked the therapeutic tier behind the vet counter. Specialty retail's fresh opportunity is still real, but it's now officially the wellness lane, and the customer's vet is in the fresh conversation whether you like it or not.

Get the next issue in your inbox. Free, weekly, no fluff.

Unsubscribe anytime.

Source: Pet Age

← Back to the Newsdesk